This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Apr 29;355(9214):1474-5.

doi: 10.1016/S0140-6736(00)02155-3.

Choice of hormonal therapy for prostate cancer

D M Reese¹

Affiliations

PMID: 10801162
DOI: 10.1016/S0140-6736(00)02155-3

Comment

Choice of hormonal therapy for prostate cancer

D M Reese. Lancet. 2000.

. 2000 Apr 29;355(9214):1474-5.

doi: 10.1016/S0140-6736(00)02155-3.

Author

D M Reese¹

Affiliation

¹ Urologic Oncology Program, University of California San Francisco Mount Zion Cancer Center, 94115, USA.

PMID: 10801162
DOI: 10.1016/S0140-6736(00)02155-3

No abstract available

PubMed Disclaimer

Comment on

Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists' Collaborative Group.
[No authors listed] [No authors listed] Lancet. 2000 Apr 29;355(9214):1491-8. Lancet. 2000. PMID: 10801170

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information